Examining the Reliability and Validity of the New York Heart Association Classification Guide to Assign Class for Patients With Heart Failure and Application Into Practice

Status: Unknown
Location: See all (3) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Heart failure (HF) is a major public health problem. The New York Heart Association (NYHA) Functional Classification by a HF provider helps to guide their decisions in patient treatment. The purpose of this study is to further examine the NYHA Classification Guide that is designed to assist healthcare providers. The investigators will conduct the study in the outpatient clinic setting where adult patients with chronic heart failure are treated. HF providers will be asked to complete the NYHA classification Guide and then participants will complete a standardized 6-minute walk test which is considered as the gold standard. Participant results will be compared between providers' assigned class and the results from the 6-minute walk test. The subsequent phase of the study will be incorporation of the NYHA Classification Guide into clinical practice. HF providers will use the NYHA Classification Guide for 30 days in the clinic setting and will report their perceptions.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: t
View:

• A documented confirmed diagnosis of Heart Failure (HF)

• Under the care of a Cardiologist and/or Advanced Practice Provider working in Cardiology

• 18 years of age or older and less than 90 years of age

• Alert and oriented to person, place, and time

• Ability to walk without assistance

• Able to read and speak English

⁃ • Licensed healthcare providers (Physicians and Advance Practice Providers) in HF ambulatory clinical sites who care for adult patients with HF.

Locations
United States
Colorado
University of Colorado Medical Center
NOT_YET_RECRUITING
Aurora
Illinois
Carle BroMenn Medical Center
RECRUITING
Normal
Pennsylvania
Lancaster General Health/Penn Medicine
NOT_YET_RECRUITING
Lancaster
Contact Information
Primary
Marilyn A. Prasun, PhD
maprasu@ilstu.edu
217-433-2316
Backup
Kelly D. Stamp, PhD
Kelly.Stamp@CUAnschutz.edu
303-724-8398
Time Frame
Start Date: 2023-03-17
Completion Date: 2024-06-17
Participants
Target number of participants: 104
Treatments
Experimental: Single Intervention Study Arm
All participants with HF will be evaluated by their HF providers who will use the NYHA Classification Guide to assist with assignment of HF class. The participant will then complete a 6-minute walk test. Subsequently participating providers will utilize the guide to assess and assign the class of their HF patients in practice.
Sponsors
Collaborators: Lancaster General Hospital, University of North Carolina, Greensboro, Abbott, University of Colorado, Denver
Leads: Board of Trustees of Illinois State University

This content was sourced from clinicaltrials.gov